Grants per year
Grants
- 6 Finished
Search results
-
Finished
Prot #IVXCpn001: Efficacy, Safety and Impact on Biomarkers of Ala-Chaperonin 10 In subjects with mildly active Systemic Lupus Erythematosus
5/23/14 → 5/23/17
Project: Research project
-
-
Prot# SL0010: A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of The Efficacy and Safety of four 12-week Treatment Cycles (48 weeks total) Of Epratuzumab in Systematic Lupus Erythematosus Subjects With Moderate To Severe Disease
Parexel, UCB Biosciences, Inc.
12/13/11 → 12/13/14
Project: Research project
-
Prot# GHO-09-1621: Lupus Impact Tracker: A Longitudinal Validation Study
Ramsey-Goldman, R. & Hsieh, C.
Kendle International Inc., GlaxoSmithKline LLC
9/14/11 → 9/14/14
Project: Research project